SONOMA PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $55.00K.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $266.00K, a 66.33% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $790.00K, a 45.37% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.54M.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2024 was $1.45M.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2020 was $1.38M, a 43.78% increase from fiscal 2019.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2019 was $957.00K, a 82.50% decline from fiscal 2018.
- SONOMA PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2018 was $5.47M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $55.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $266.00K 10-Q · filed 2026-02-10 | |
| 2024-12-31 | $790.00K 10-Q · filed 2026-02-10 | |
| 2024-09-30 | $1.54M 10-Q · filed 2026-02-10 | |
| 2024-06-30 | $748.00K 10-Q · filed 2026-02-10 | |
| 2024-03-31 | $1.45M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $1.45M 10-Q · filed 2024-02-08 | |
| 2021-09-30 | $6.90M 10-Q · filed 2023-02-14 | |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-14 | $1.38M 10-K · filed 2021-07-14 |
| 2019-12-31 | $1.38M 10-Q · filed 2021-02-16 | |
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | $957.00K 10-K · filed 2020-07-10 |
| 2018-12-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | |
| 2018-09-30 | $42.00K 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $5.47M 10-K · filed 2019-07-01 | |
| 2016-03-31 | $2.99M 10-K · filed 2017-06-28 | |
| 2015-03-31 | $5.44M 10-K · filed 2016-06-21 | |
| 2014-03-31 | $3.19M 10-K · filed 2015-06-16 | |
| 2013-03-31 | $4.94M 10-K · filed 2014-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |